Glenmark Pharmaceuticals
GLENMARK.NS
#2590
Rank
NZ$9.34 B
Marketcap
$33.09
Share price
0.55%
Change (1 day)
106.90%
Change (1 year)

Glenmark Pharmaceuticals (GLENMARK.NS) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : NZ$1.30 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company's total liabilities are NZ$1.30 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Glenmark Pharmaceuticals - Total liabilities on balance sheet (from 2012 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31NZ$1.85 B28.03%
2022-03-31NZ$1.44 B-13.01%
2021-03-31NZ$1.66 B-12.54%
2020-03-31NZ$1.90 B16.76%
2019-03-31NZ$1.62 B3.28%
2018-03-31NZ$1.57 B-1.64%
2017-03-31NZ$1.60 B11.84%
2016-03-31NZ$1.43 B0.49%
2015-03-31NZ$1.42 B31.25%
2014-03-31NZ$1.08 B12.66%
2013-03-31NZ$0.96 B16.46%
2012-03-31NZ$0.82 B-7.19%
2011-03-31NZ$0.89 B12.37%
2010-03-31NZ$0.79 B-14.94%
2009-03-31NZ$0.93 B104.97%
2008-03-31NZ$0.45 B11.91%
2007-03-31NZ$0.40 B16.13%
2006-03-31NZ$0.35 B85.12%
2005-03-31NZ$0.18 B147.59%
2004-03-31NZ$76.47 M